Pre-Open Movers 4/22: (RVNC) (AGN) (NFLX) Higher; (MDSO) (BEBE) (RMBS) Lower (more...)

April 22, 2014 9:23 AM EDT Send to a Friend

Revance Therapeutics, Inc. (Nasdaq: RVNC) 19.5% HIGHER; announced positive data from its Phase 1/2 study of RT002 injectable botulinum toxin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Pre-Open Movers 4/22: (RVNC) (AGN) (NFLX) Higher; (MDSO) (BEBE) (RMBS) Lower (more...)

Member Login

Free News Feed